Forthcoming live webinars
Register to view the live broadcast of these forthcoming webinars.
This webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. Boehringer Ingelheim Limited has reviewed the scope of the webinar, commissioned the speaker, and approved all materials related to the webinar. The speaker has been paid an honorarium. The views and ...
On demand webinars
These are recordings of live webinars that are now available on demand.
Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)
This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.